Friends Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Philly NavSTAR Implementation Trial

Not Applicable

Active, not recruiting

Conditions: Opioid Use Disorder

First Posted Date: 2024-10-09

Last Posted Date: 2025-06-15

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 32

Registration Number: NCT06634277

Locations: 🇺🇸
Jefferson Health, Philadelphia, Pennsylvania, United States
🇺🇸
Friends Research Institute, Philadelphia, Pennsylvania, United States

Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and MHealth Platform

Not Applicable

Conditions: Opioid Use Disorder

First Posted Date: 2024-08-27

Last Posted Date: 2025-03-18

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 180

Registration Number: NCT06573476

Locations: 🇺🇸
START Treatment and Recovery, New York City, New York, United States

Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids

Not Applicable

Recruiting

Conditions: Opioid Use Disorder

First Posted Date: 2024-08-26

Last Posted Date: 2025-01-08

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 292

Registration Number: NCT06569667

Locations: 🇺🇸
NYC Health + Hospitals, Bronx, New York, United States

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

Not Applicable

Terminated

Conditions: HIV

First Posted Date: 2024-05-10

Last Posted Date: 2025-04-17

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 71

Registration Number: NCT06408350

Locations: 🇺🇸
Friends Community Center, Los Angeles, California, United States

Buprenorphine for Individuals in Jail

Phase 3

Active, not recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: extended-release buprenorphine (XR-B)

First Posted Date: 2024-03-12

Last Posted Date: 2025-03-17

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 240

Registration Number: NCT06306443

Locations: 🇺🇸
Friends Research Institute, Baltimore, Maryland, United States
🇺🇸
Baltimore Central Booking & Intake Center, Baltimore, Maryland, United States

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

Phase 4

Active, not recruiting

Conditions: Opioid Use Disorder

Interventions: Drug: buprenorphine/naloxone

First Posted Date: 2023-07-14

Last Posted Date: 2025-03-17

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 40

Registration Number: NCT05944952

Locations: 🇺🇸
MATClinics, Dundalk, Maryland, United States

ASK-PrEP (Assistance Services Knowledge-PrEP)

Not Applicable

Terminated

Conditions: Substance Use Disorders
HIV

First Posted Date: 2023-07-07

Last Posted Date: 2025-04-17

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 152

Registration Number: NCT05934877

Locations: 🇺🇸
Friends Community Center, Los Angeles, California, United States

Treating Polysubstance Use Using a Novel Digital Technology

Phase 3

Recruiting

Conditions: Cocaine Use
Cocaine Use Disorder
Opioid Use
Opioid Use Disorder

Interventions: Drug: Methadone Treatment-As-Usual
Behavioral: DynamiCare Health

First Posted Date: 2023-03-13

Last Posted Date: 2025-01-06

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 240

Registration Number: NCT05766631

Locations: 🇺🇸
Friends Research Institute, Inc. Central Office, Baltimore, Maryland, United States
🇺🇸
Glenwood Life Counseling Center, Baltimore, Maryland, United States
🇺🇸
Institutes for Behavior Resources, Baltimore, Maryland, United States

and more 2 locations

Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living with HIV Who Use Substances

Not Applicable

Active, not recruiting

Conditions: Opioid Use
Cocaine Use
Stigma, Social
HIV

First Posted Date: 2023-01-30

Last Posted Date: 2025-03-19

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 70

Registration Number: NCT05704764

Locations: 🇺🇸
Friends Research Institute, Inc. Office Building, Cerritos, California, United States
🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine

Phase 2

Conditions: Opioid-use Disorder

Interventions: Behavioral: Patient Navigation
Drug: Buprenorphine

First Posted Date: 2021-08-05

Last Posted Date: 2023-03-23

Lead Sponsor: Friends Research Institute, Inc.

Target Recruit Count: 360

Registration Number: NCT04991974

Locations: 🇺🇸
Friends Research Institute, Baltimore, Maryland, United States
🇺🇸
Baltimore City Health Department Sexual Health Clinics, Baltimore, Maryland, United States

AI-Powered Research

Premium Access

Friends Research Institute, Inc.

Philly NavSTAR Implementation Trial

Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and MHealth Platform

Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

Buprenorphine for Individuals in Jail

Low-dose Versus a High-dose Sublingual Buprenorphine Induction

ASK-PrEP (Assistance Services Knowledge-PrEP)

Treating Polysubstance Use Using a Novel Digital Technology

Using the Ending Self-Stigma Intervention to Reduce Internalized Stigma Among People Living with HIV Who Use Substances

Opioid Use Disorder Treatment Linkage at Sexual Health Clinics Using Buprenorphine